Skip to main content
. 2021 Oct 12;10(10):67. doi: 10.1038/s41389-021-00356-5

Fig. 1. TRPC1 upregulation in CRC is positively correlated with tumor progression and poor prognosis of CRC patients.

Fig. 1

A Analyses of TRPCs mRNA expression in adjacent normal tissues (n = 287) and colorectal tumor tissues (n = 1994) in the GENT2 dataset. B Protein expression of TRPC1 in colorectal tumor tissues (n = 98) and adjacent normal tissues (n = 13) from the local cohort were assessed by IHC. C TRPC1 expression in 13 paired colorectal cancer and adjacent normal tissues from the local cohort were assessed by IHC. D Analyses of the TRPC1 mRNA expression in different CRC tumor stage (n = 459) in the TCGA database. E Analyses of TRPC1 mRNA levels in primary colorectal tumors (n = 365) and metastasis tumors (n = 60) in the TCGA database. F Kaplan–Meier survival analysis of overall survival according to the TRPC1 mRNA expression in the TCGA database. High TRPC1 expression predicts poor overall survival in colorectal cancer. G Kaplan–Meier survival analysis of overall survival according to the TRPC1 mRNA expression in CRC patients with stage I/II or stage III/IV in the TCGA database. H Analyses of the TRPC1 protein expression in primary colorectal tumors (n = 61) and metastasis tumors (n = 37) in local cohort by IHC. I TRPC1 was frequently upregulated in CRC cell lines as determined by Western blot analysis (n = 3). **P < 0.01 vs. NCM460 group. **P < 0.01.